ProQR CEO Daniel Anton de Boer acquires 200,000 shares for $353,960

ProQR Therapeutics CEO Daniel Anton de Boer purchased 200,000 ordinary shares at $1.77 per share for a total of $353,960. This transaction increased his direct holdings to 500,000 shares. The information was published via EDGAR on August 3, 2026.

ProQR Therapeutics CEO Daniel Anton de Boer bought 200,000 ordinary shares at $1.77, lifting direct holdings to 500,000 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-089780), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

PRQR